marketcaparena
Search

    ESLA

    Estrella Immunopharma, Inc.

    Company overview

    Market capitalization
    $18.76M
    Employees
    0
    Latest publication
    2026-09-29
    About Estrella Immunopharma, Inc.

    Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in Phase I/II clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It offers ARTEMIS, a cell receptor platform to develop and commercialize T-cell therapies targeting CD19 and CD22 for the treatment of hematologic malignancies. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California. Estrella Immunopharma, Inc. is a subsidiary of Eureka Therapeutics, Inc.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue0USD0USD0USD0USD0USD—0USD0USD
    Research Development1,400,275USD25,414USD4,152,642USD4,660,301USD1,410,188USD32,565USD2,826,000USD3,525,000USD
    Selling General Administrative891,789USD587,785USD648,507USD883,727USD694,110USD—550,737USD424,447USD
    Total Operating Expenses2,292,064USD613,199USD4,801,149USD5,544,028USD2,104,298USD1,050,227USD3,376,737USD3,949,447USD
    Operating Income-2,292,064USD-613,199USD-4,801,149USD-5,544,028USD-2,104,298USD-1,050,227USD-3,376,737USD-3,949,447USD
    Income Before Tax-2,292,064USD-613,199USD-4,801,149USD-5,544,028USD-2,104,298USD-1,050,227USD-3,376,737USD-3,949,447USD
    Tax Provision0USD-25USD0USD850USD13USD—0USD1,625USD
    Net Income-2,292,064USD-613,174USD-4,801,149USD-5,544,878USD-2,104,311USD-1,050,290USD-3,376,737USD-3,951,072USD
    Net Income From Continuing Ops-2,292,064USD-613,174USD-4,801,149USD-5,544,878USD-2,104,311USD—-3,376,737USD-3,951,072USD
    Ebitda-2,292,064USD-613,199USD-4,801,149USD-5,544,028USD-2,104,298USD-1,050,227USD-3,376,737USD-3,949,447USD
    Total Other Income Expense Net-108,627USD———————
    Income Tax Expense—-25USD—850USD13USD63USD1,625USD1,625USD
    Ebit———-5,544,028USD-2,104,298USD-1,050,227USD-3,376,737USD-3,949,447USD
    Unclassified Operating Expenses—————1,017,662USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USD
    Total Revenue0USD—0USD0USD0USD0USD
    Research Development10,248,545USD6,408,565USD4,108,925USD6,441,547USD1,389,099USD457,231USD
    Selling General Administrative2,814,129USD1,419,714USD3,201,173USD442,680USD296,248USD276,462USD
    Total Operating Expenses13,062,674USD8,845,941USD7,310,098USD1,569,529USD1,685,347USD733,693USD
    Operating Income-13,062,674USD-8,845,941USD-7,310,098USD-1,569,530USD-1,685,347USD-733,693USD
    Income Before Tax-13,062,674USD-8,845,941USD-7,310,098USD-915,456USD-1,685,347USD-733,693USD
    Income Tax Expense838USD1,688USD—80,648USD-235,136USD-206,297USD
    Tax Provision838USD—1,625USD0USD0USD0USD
    Net Income-13,063,512USD-8,847,629USD-7,311,723USD-996,104USD-1,685,347USD-733,693USD
    Net Income From Continuing Ops-13,063,512USD—-7,311,723USD-6,884,227USD-1,685,347USD-733,693USD
    Ebitda-13,062,674USD-8,845,941USD—-686,971USD-1,685,347USD-733,693USD
    Unclassified Operating Expenses—1,017,662USD—-5,314,698USD——
    Ebit—-8,806,355USD-7,310,098USD-915,456USD-1,685,347USD-733,693USD
    Depreciation And Amortization—-39,586USD—228,485USD236,558USD206,297USD
    Total Other Income Expense Net———654,074USD1,422USD—
    Net Income Applicable To Common Shares———-11,114,402USD-1,074,151USD-733,693USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,824,681USD3,657,198USD3,176,975USD3,523,511USD2,980,527USD2,444,268USD3,140,777USD3,735,145USD
    Cash And Equivalents100,000USD———————
    Total Current Assets1,824,681USD2,157,198USD1,676,975USD2,023,511USD1,480,527USD944,268USD1,640,777USD2,235,145USD
    Other Current Assets178,011USD229,794USD292,673USD—163,933USD522,795USD723,861USD437,642USD
    Total Liabilities9,256,014USD———————
    Total Current Liabilities9,256,014USD8,927,494USD13,543,033USD13,359,934USD9,075,195USD4,275,215USD2,997,046USD2,988,859USD
    Total Stockholder Equity-7,431,333USD-5,270,296USD-10,366,058USD-9,836,423USD-6,094,668USD-1,830,947USD143,731USD746,286USD
    Total Equity Including Noncontrolling Interest-7,431,333USD———————
    Common Stock4,355USD4,318USD3,849USD3,828USD3,758USD3,668USD3,668USD3,661USD
    Retained Earnings-41,589,218USD-39,282,879USD-36,990,815USD-36,377,641USD-31,576,492USD-26,031,614USD-23,927,303USD-22,877,013USD
    Total Liab—8,927,494USD13,543,033USD13,359,934USD9,075,195USD4,275,215USD2,997,046USD2,988,859USD
    Other Current Liab—8,912,547USD12,988,252USD13,346,387USD9,063,041USD4,261,177USD2,997,046USD3,020,444USD
    Capital Stock—4,318USD3,849USD3,828USD3,758USD3,668USD—3,661USD
    Cash—1,927,404USD1,384,302USD1,626,610USD1,316,594USD421,473USD916,916USD1,797,503USD
    Cash And Short Term Investments—1,927,404USD1,384,302USD1,626,610USD1,316,594USD421,473USD916,916USD1,797,503USD
    Net Debt—-1,927,404USD-1,384,302USD-1,622,610USD-1,316,594USD-421,473USD-916,916USD-1,797,503USD
    Accounts Payable—14,947USD554,781USD5,631USD8,154USD13,988USD—9,337,644USD
    Common Stock Shares Outstanding—42,121,075shares37,970,938shares37,096,024shares36,165,589shares36,188,293shares36,680,870shares36,208,477shares
    Non Current Assets Total—1,500,000USD1,500,000USD1,500,000USD1,500,000USD1,500,000USD1,500,000USD1,500,000USD
    Non Current Liabilities Total—0USD0USD0USD0USD0USD—0USD
    Non Currrent Assets Other—1,500,000USD1,500,000USD1,500,000USD1,500,000USD1,500,000USD1,500,000USD1,500,000USD
    Net Working Capital—-6,770,296USD-11,866,058USD-11,336,423USD-7,594,668USD-3,330,947USD—-753,714USD
    Unclassified Equity—34,003,947USD26,617,059USD26,533,562USD25,474,308USD24,193,331USD24,067,366USD28,070,166USD
    Short Term Debt———4,000USD4,000USD———
    Short Long Term Debt Total———4,000USD4,000USD———
    Net Receivables———396,901USD163,933USD522,795USD—437,642USD
    Inventory———————-288,760USD
    Accumulated Other Comprehensive Income———————-4,454,189USD
    Unclassified Current Liabilities———————-9,369,229USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USD
    Total Assets3,176,975USD3,140,777USD4,454,189USD9,986,484USD4,921,666USD0USD
    Other Current Assets292,673USD723,861USD—11,625USD833,333USD—
    Total Liab13,543,033USD2,997,046USD180,701USD2,915,723USD5,961,509USD0USD
    Total Stockholder Equity-10,366,058USD143,731USD4,273,488USD7,070,761USD-1,039,843USD0USD
    Other Current Liab12,988,252USD2,997,046USD—9,161,569USD-945,587USD—
    Common Stock3,849USD3,668USD—9,326,588USD18USD—
    Capital Stock3,849USD—3,661USD5,000,098USD18USD0USD
    Retained Earnings-36,990,815USD-23,927,303USD-19,500,276USD-2,255,827USD-1,074,151USD0USD
    Cash1,384,302USD916,916USD4,165,428USD40,802USD4,088,333USD0USD
    Cash And Short Term Investments1,384,302USD916,916USD—40,802USD4,088,333USD—
    Total Current Assets1,676,975USD1,640,777USD4,454,189USD52,427USD4,921,666USD0USD
    Total Current Liabilities13,543,033USD2,997,046USD180,701USD1,073,069USD946,684USD0USD
    Net Debt-1,384,302USD-916,916USD—457,798USD-4,088,333USD—
    Accounts Payable554,781USD—0USD46,879USD945,587USD0USD
    Common Stock Shares Outstanding36,820,810shares36,680,870shares36,289,076shares5,762,911shares5,849,700shares35,201,232shares
    Non Current Assets Total1,500,000USD1,500,000USD0USD9,934,057USD45,187,428USD0USD
    Non Current Liabilities Total0USD—0USD1,842,653USD5,014,825USD0USD
    Non Currrent Assets Other1,500,000USD1,500,000USD————
    Net Working Capital-11,866,058USD—4,273,488USD-7,006,012USD3,974,982USD0USD
    Unclassified Equity26,617,059USD24,067,366USD23,770,103USD-5,000,098USD——
    Net Receivables—288,761USD—273,066USD——
    Deferred Long Term Liab———276,187USD——
    Other Liab———12,725USD14,825USD—
    Other Assets———276,187USD-45,187,428USD—
    Short Term Debt———498,600USD——
    Short Long Term Debt Total———498,600USD——
    Non Current Liabilities Other———12,725USD14,825USD—
    Net Tangible Assets———-11,742,550USD-1,039,843USD—
    Unclassified Non Current Assets———9,657,870USD45,187,428USD—
    Unclassified Current Liabilities———-8,633,979USD——
    Unclassified Non Current Liabilities———1,541,016USD4,985,175USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Stock Based Compensation292,012USD
    Change In Working Capital114,662USD
    Operating Cash Flow-8,478,748USD
    Financing Cash Flow7,241,116USD
    Change In Cash-1,237,632USD
    End Cash Flow146,670USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-2,292,064USD-613,174USD-4,801,149USD-5,544,878USD-2,104,311USD-1,050,290USD-3,376,737USD-3,951,072USD
    Stock Based Compensation146,714USD148,360USD152,421USD159,098USD159,095USD—0USD0USD
    Other Non Cash Items255,341USD-28,850USD67,039USD——432,256USD1,159,277USD—
    Change In Working Capital-4,661,287USD316,177USD3,854,357USD4,970,901USD1,479,235USD-278,032USD1,159,277USD3,659,559USD
    Total Cash From Operating Activities-6,698,010USD-177,487USD-727,332USD-414,879USD-465,981USD-896,066USD-2,217,460USD-291,513USD
    Capital Expenditures0USD0USD0USD0USD0USD-4USD-3USD-3USD
    Free Cash Flow-6,698,010USD-177,487USD-727,332USD-414,879USD-465,981USD-896,070USD-2,217,460USD-291,510USD
    Total Cash From Financing Activities7,241,112USD-64,821USD1,037,348USD1,310,000USD-29,462USD15,479USD-150,465USD-270,349USD
    Sale Purchase Of Stock0USD-150,465USD29,462USD121,003USD-29,462USD-64,012USD-150,465USD-270,349USD
    Issuance Of Capital Stock7,999,988USD0USD1,050,000USD———0USD0USD
    Change In Cash543,102USD-242,308USD310,016USD895,121USD-495,443USD-880,587USD-2,367,925USD-561,862USD
    Begin Period Cash Flow1,384,302USD1,626,610USD1,316,594USD421,473USD916,916USD1,797,503USD4,165,428USD4,727,290USD
    End Period Cash Flow1,927,404USD1,384,302USD1,626,610USD1,316,594USD421,473USD916,916USD1,797,503USD4,165,428USD
    Other Cashflows From Financing Activities-758,882USD-64,821USD-12,652USD-40,000USD——-150,465USD—
    Unclassified Financing Cash Flow7,999,994USD—1,020,538USD1,228,997USD————
    Investments——————0USD0USD
    Net Borrowings——————0USD0USD
    Unclassified Operating Cash Flow——————-1,159,277USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USD
    Net Income-13,063,512USD-8,847,629USD-7,311,723USD-996,104USD-1,685,347USD-733,693USD
    Stock Based Compensation618,974USD1,194,653USD1,194,653USD299,915USD129,968USD62,873USD
    Other Non Cash Items657,163USD509,332USD—-654,071USD-1,428USD—
    Change In Working Capital10,620,670USD775,700USD-9,951,236USD576,855USD113,351USD0USD
    Total Cash From Operating Activities-1,785,679USD-7,639,673USD-16,068,306USD-1,043,848USD-1,442,028USD-670,820USD
    Capital Expenditures0USD-1USD0USD0USD0USD0USD
    Free Cash Flow-1,785,680USD-7,639,674USD-16,068,306USD-1,043,848USD-1,442,028USD-670,820USD
    Total Cash From Financing Activities2,253,065USD-489,426USD12,793,941USD-35,564,343USD5,530,361USD670,820USD
    Sale Purchase Of Stock-29,462USD-568,917USD-354,440USD-36,112,943USD-25,000USD—
    Issuance Of Capital Stock2,400,000USD—9,020,000USD0USD5,000,000USD0USD
    Change In Cash467,386USD-8,129,099USD1,686,282USD-438,066USD4,088,333USD4,088,333USD
    Begin Period Cash Flow916,916USD9,046,015USD2,479,146USD478,868USD0USD0USD
    End Period Cash Flow1,384,302USD916,916USD4,165,428USD40,802USD4,088,333USD0USD
    Other Cashflows From Financing Activities-117,473USD9,579,186USD—50,000USD5,530,361USD670,820USD
    Unclassified Financing Cash Flow2,400,000USD-9,499,695USD13,148,381USD———
    Total Cashflows From Investing Activities—4,960,647USD—36,170,124USD-45,186,000USD-273,066USD
    Other Cashflows From Investing Activities—4,960,647USD—-273,066USD-273,066USD-273,066USD
    Unclassified Operating Cash Flow—-1,271,729USD————
    Investments——4,960,647USD-273,066USD0USD0USD
    Net Borrowings——0USD0USD——
    Change To Liabilities———8,387,559USD0USD0USD
    Unclassified Investing Cash Flow———36,716,256USD-44,912,934USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.